Duchenne muscular dystrophy is a recessive disease due to a mutation in the dystrophin gene. Myoblast transplantation permits to introduce the dystrophin gene in dystrophic muscle fibers. However, the success of this approach is reduced by the short duration of the regeneration following the transplantation, which reduces the number of hybrid fibers. Our aim was to verify whether the success of the myoblast transplantation is enhanced by blocking the myostatin signal with an antagonist, follistatin. Three different approaches were studied to overexpress follistatin in the muscles of mdx mice transplanted with myoblasts. First, transgenic follistatin/mdx mice were generated; second, a follistatin plasmid was electroporated in mdx muscles, and finally, follistatin was induced in mdx mice muscles by a treatment with a histone deacetylase inhibitor. The three approaches improved the success of the myoblast transplantation. Moreover, fiber hypertrophy was also observed in all muscles, demonstrating that myostatin inhibition by follistatin is a good method to improve myoblast transplantation and muscle function. Myostatin inhibition by follistatin in combination with myoblast transplantation is thus a promising novel therapeutic approach for the treatment of muscle wasting in diseases such as Duchenne muscular dystrophy.
INTRODUCTION
factor-β family expressed predominantly in skeletal muscle tissue (19) , is a powerful inhibitor of muscle growth (14) . Indeed, mutations in the myostatin gene or Duchenne muscular dystrophy (DMD), a severe Xlinked genetic disease (5), is due to a dystrophin gene inactivation of the myostatin protein in mice, cattle, and even in a human subject result in important increases mutation, which causes an absence of dystrophin expression and is characterized by a progressive skeletal mus-in skeletal muscle mass (11, 15, 24) . Actually, myostatin negatively regulates skeletal muscle growth by decreas-cle atrophy (7) . The absence (in DMD) or dysfunction (in Becker muscular dystrophy) of this protein leads to ing the myoblast proliferation rate and by delaying its terminal differentiation. Myostatin is also implicated in the myofiber membrane instability (3). Myoblast transplantation in dystrophic muscle results in the long-term the muscle regeneration process (12,23), by blocking the satellite cell activation (17) and macrophage migration restoration of this protein after the fusion of the transplanted myoblasts with each other or with damaged host and thus the inflammatory response that occurs after muscle damage (18) . muscle fibers (21) . However, the success of this approach is reduced by the limited regeneration period fol-Follistatin is a secreted glycoprotein encoded by a single gene that is subject to alternative splicing. This lowing muscle damage produced by the intramuscular injections of myoblasts (26) . This limitant factor can be mechanism generates two different forms of the protein: the short (FS288) and the long form (FS344). The short bypassed by repetitive cell injections very close to each other as demonstrated previously (25) .
form of follistatin lacks the acidic tail in the C-terminal, which permits the protein to bind to the extracellular Myostatin, a member of the transforming and growth matrix and thus to be less diluted in the circulation (10). from tibialis anterior (TA) muscles of mdx and mdx/ hFst). The forward primer was 5′-GCCTGCTTCCTCT Follistatin is known to antagonize the function of myostatin (1). Indeed, experimental overexpression of follis-GAGCAAT-3′ and the reverse primer was 5′-AGAGG GAACACCGGCCTCTC-3′. Mouse glyceraldehyde-3-tatin in mice under a skeletal muscle-specific promoter results in muscle enlargement (15). This inhibition oc-phosphate dehydrogenase (GAPDH) gene was also amplified as an internal control using 5′-GGAAGGGCT curs after the formation of a latent complex between mature myostatin and follistatin, making myostatin unable CATGACCACA-3′ as a forward primer and 5′-CCGTT CAGCTCTGGGATGAC-3′ as a reverse primer. to attach its specific receptor (6).
In addition, cell proliferation and differentiation are A Western blot on proteins prepared from TA of mdx or mdx/hFst mice and β-Gal or hFst electroporated mice strongly influenced by protein acetylation. In skeletal muscle cells, it has been demonstrated that acetylation was also done using a mouse anti-human follistatin antibody (R & D Systems Inc., MN, USA) and an anti-favors the differentiation process (8). Indeed, the inhibition of the histone deacetylase in myoblasts (C2C12 cell mouse horseradish peroxidase-coupled antibody (DAKO A/S, Denmark). line and human muscle cells) results in the formation of larger myotubes with increased numbers of nuclei (8).
Rota Rod and Force Grip Assay Moreover, it has been recently reported that this enhanced fusion of myoblasts exposed to histone deacety-
The Rota Rod (Columbus Instruments, OH, USA) started at stop position and accelerated at the rate of 18 lase inhibitor is mediated by a follistatin overexpression counteracting the myostatin activity on those myoblasts (9). revolutions per minute. Each mouse was allowed to remain on the rod until it felt off. Two trials were per-Our purpose was first to verify whether muscle function and myoblast transplantation success were improved formed for each group of mice, and the best length of time that each mouse remained on the rod was recorded in mdx mice overexpressing follistatin. We also blocked the myostatin signal in mdx mice with follistatin either as endurance time for that animal. Mice were acclimated with the apparatus during six sessions (two sessions per directly by electroporating a plasmid coding for follistatin or indirectly by treating the mice with a histone week), and the represented results were recorded at the seventh session. deacetylase inhibitor (trichostatin A), and studied the consequences of this inhibition on myoblast transplanta-The automated grip strength meter (Columbus Instruments) was positioned horizontally and mice held by the tion and on muscle histological features.
base of the tail allowed to grasp the grid and were then MATERIALS AND METHODS pulled backward in the horizontal plane. The force ap-Animals plied to the bar at the moment the grasp was released All the experiments were approved by the animal was recorded as the peak tension [kg converted in N: care committee of the CHUL (Centre Hospitalier de force (in N) = mass (in kg) × 9.8 (N/kg)] by an elecl'Université Laval). The mdx (dystrophic mouse model tronic strain gauge. The test was repeated five consecuon a C57BL10J genetic background) mice were purtive times within the same session and the highest value chased from Jackson Laboratory (Bar Harbor, ME). from the five trials was recorded as the grip strength for Transgenic mice overexpressing the human follistatin that animal. Mice were acclimated with the apparatus short form (on C57BL6J genetic background) were graduring three sessions (three sessions per week), and the ciously given by Dr. Se-Jin Lee (Department of Molecurepresented results were recorded at the fourth session. lar Biology and Genetics, Johns Hopkins University All mice were allowed to acclimate with the apparatus School of Medicine, Baltimore, MD).
during 5 min before each trial. A total of four mice in each group were used in each test.
Transgenic Dystrophic Mouse Generation
Nondystrophic male mice overexpressing the human Cross-Section Area Measurements follistatin short form protein (hFst) were crossed with A hematoxylin and eosin staining and an immunohismdx female mice. All males in the F 1 generation were tochemistry detection of mouse caveolin-3 (BD Bioscidystrophic because the dystrophin gene is carried on the ences, ON, Canada) were done on TA muscle sections X chromosome. Moreover, all those males were transfrom mdx and mdx/hFst mice. Each muscle section (two genic for the follistatin gene because the human follissections were analyzed for each group of mice) was photatin short-form gene was located on the Y chromosome tographed with a Nikon 4 MP camera. The total or sinin the nondystrophic males crossed with the mdx females.
gle fiber cross-section area of each muscle was deter-Follistatin Protein Quantification mined using Scion image software. For the single fiber cross-section area, three different zones of each section A PCR for the human follistatin gene was performed on the cDNA [reverse transcribed from RNA prepared were photographed and the cross-section area of each fiber on each muscle section was recorded; all fibers were immunosuppressed from the day of the transplantation and sacrificed after 6 weeks. Dystrophin-positive were then classified into different classes of fiber crosssection area. The percentage of fibers within each class fibers were revealed by immunohistochemistry as previously described (2). was calculated.
Myoblast Preparation
Statistical Analysis Primary muscle cultures were prepared using a modi-Differences among groups were statistically analyzed fied preplating technique from newborn (2-3 days old)
with an analysis of variance (ANOVA) test using the C57BL/10J mice (22) . Cell suspension, obtained after stat-view software (Brainpower, Cala-Basas, CA). A value the enzymatic digestion of the muscle tissue, was alof p < 0.05 was considered significant. lowed to attach for 48 h. Only adherent cells were used for the transplantations. Desmin labeling was performed RESULTS on a sample of the culture to establish the percentage of myoblasts (about 70%). Cell viability was also verified
Overexpression of Human Follistatin in TA Muscles using trypan blue staining.
of Transgenic Dystrophic Mice PCR and Western blot studies (data not shown) showed Plasmid Electrotransfer that the human follistatin transcript and protein were Six 3-month-old mdx mice were used for this expericlearly overexpressed in TA muscle of transgenic dysment. Three mice were used for each plasmid. Forty mitrophic mice compared with those of nontransgenic dyscrograms of each plasmid (pCMV-β-Gal or pCMVtrophic mice. hFst) was slowly injected in a total volume of 40 µl of 0.9% sterile NaCl in TA muscles of mdx mice. After Improvement of Whole Body and TA Skeletal Muscle the intramuscular injection, electric pulses were applied Weight in Transgenic Dystrophic Mice using two stainless steel plate electrodes placed on either side of the hind limb (27) .
Transgenic dystrophic males showed increased muscling; in fact, whole body and TA muscle weights were Trichostatin A Treatment increased by 125% and 186%, respectively, in trans-Eight 2-month-old mdx mice were used for this exgenic dystrophic males (mdx/hFst) relative to the same periment. Four mice were treated daily with IP trichosage control dystrophic animals ( Fig. 1a, b ). tatin A (TSA) (Sigma Aldrich, MO, USA), and four were used as a controls and were injected daily with
Increasing of Cross-Section Area and Single Fiber Hank's buffered salt solution (HBSS) (20) .
Cross-Section Area in TA Muscle of Transgenic Dystrophic Mice Myoblast Long-Term Transplantation
Myoblasts were transplanted in TA muscles follow-The results in Figure 1c show that the total crosssection area of whole TA muscles of transgenic dystro-ing the protocol described in Benabdallah et al.
(2). Mice were immunosuppressed with daily injection of ta-phic mice was increased by 1.7-fold compared to those of control mice. Moreover, single fiber cross-section ar-crolimus (FK506 at 2.5 mg/kg). In summary, 2 million myoblasts resuspended in HBSS were transplanted in eas were also bigger in mdx/hFst mice compared to those of mdx mice; this suggests that the increases of each TA muscle of four mdx mice (4 months old) and four mdx/hFst mice (4 months old); all mice were immu-both muscle weight and whole muscle cross-section area are due in a large part to fiber hypertrophy. Indeed, the nosuppressed from the day of the transplantation and sacrificed 3 weeks after the transplantation. Myoblasts frequency histogram in Figure 1e clearly shows different size distributions in muscles from mdx and mdx/hFst (500,000) resuspended in HBSS containing cardiotoxin (100 µg/ml) were transplanted 5 days after the electro-mice, with a shift toward larger fibers observed in mdx/ hFst mice. Indeed, below 900 units 2 , there is a higher transfer in each electroporated (pCMV-β-Gal or pCMV-hFst) TA muscle of six mdx mice (3 months old). All percentage of mdx than of mdx/hFst fibers, while above 900 units 2 there are more mdx/hFst fibers than mdx fi-mice were immunosuppressed from the day of the electrotransfer until their sacrifice 4 weeks later. Two mil-bers. In addition, the mean fiber cross-section area is significantly higher in mdx/hFst TA muscle sections lion myoblasts, resuspended in HBSS containing cardiotoxin, were transplanted in each irradiated (12 Gy) TA than in mdx TA muscle sections (Fig. 1f ). These results are in accordance with those obtained in the nondystro-muscle of eight mice (3 months old) administered or not with TSA. The myoblast transplantation was done 10 phic transgenic mice overexpressing the human follistatin protein under a muscle-specific promoter (15). days after the beginning of the TSA injection. All mice 
Improvement of Transgenic Mouse Performance
can be explained by the fact that myostatin, normally present in skeletal muscle, is inhibited by follistatin in the Rota Rod and Force Grip Tests overexpression in transgenic mice, and thus its negative As shown in Figure 2 , the mdx/hFst mice remained effect on myogenic cell proliferation and fusion is abolon the rotating rod longer than the mdx mice. Indeed, ished allowing an increased proliferation and fusion of mdx/hFst mice fell from the rod after 15 s, while mdx the transplanted cells, thus leading to the formation of mice fell after 7.5 s. This shows that follistatin overexmore dystrophin-positive hybrid fibers. pression in muscles enhanced the endurance of dystrophic mice. A force grip test was also performed on the Efficiency of the Electrotransfer Technique same animals to assess their whole body strength. Figure  2b shows that mdx/hFst mice performed better than con-Four weeks after the electrotransfer of pCMV-β-Gal, the presence of β-galactosidase-positive fibers was veri-trol mdx mice. Indeed, the total peak force generated by transgenic mice was about 2.4 N, while it was about 1.4 fied and the results (data not shown) demonstrated that the technique was effective and safe for the animals. N for control mice.
However, the number of β-galactosidase-positive fibers Improved Myoblast Transplantation Success was not equal in all electroporated muscles, indicating in Transgenic Dystrophic Mice that the effectiveness of the technique was variable. This may be due to the variability of the plasmid injections The number of dystrophin-positive fibers formed after normal myoblast transplantation was 2.6-fold as well as the behavior of the animal during the following electric shock. Western blots against follistatin were higher in TA muscles of hFst transgenic dystrophic mice compared to TA muscles of control mice (Fig. 3) . This also made on protein extracts from muscles electropora- ted with either pCMV-β-Gal or pCMV-hFst using a 4a). This treatment also induced a 60% increased weight of the TA muscles (Fig. 4b ). An immunohistochemistry mAb that reacted with both mouse and human follistatin. The blots (data not shown) showed that the follistatin against the caveolin-3 sarcolemmal protein permitted to illustrate the presence of larger fibers in pCMV-hFst was clearly more abundant in the pCMV-hFst electroporated muscles than in those electroporated with electroporated muscle sections than in the pCMV-β-Gal electroporated muscle sections (Fig. 4c ). This phenome-pCMV-β-Gal. However, the success of the electrotransfer was variable in different muscles. non was confirmed by a histogram distribution and the average size of the muscle fiber area (Fig. 4d, e ).
Increased Whole Body Weight, TA Skeletal Muscle Mass, and Single Fiber Cross-Section Area Improved Myoblast Transplantation Success Following Electrotransfer With the Follistatin Plasmid in Dystrophic Mice Electroporated With a Follistatin Plasmid
The results in Figure 5 show that the transplantation success was improved in follistatin electroporated TA Overexpression of the follistatin following electrotransfer of a follistatin plasmid directly in the TA mus-muscles. The success of the transplantation was improved by 94% after the follistatin plasmid electrotran-cles of mdx mice induced a 20% increase of the whole body weight compared with those of mice electroporated sfer compared with the control (β-galactosidase plasmid electrotransfer). Indeed, 274 dystrophin-positive fibers in their TA muscles with pCMV-β-Gal plasmid ( Fig.  Figure 4 . Increased whole body weight, TA muscle weight, and single fiber cross-section area in mdx TA muscles electroporated with pCMV-hFst. Mdx mice were electroporated with a plasmid coding either for β-galactosidase or for human follistatin. were present in follistatin electroporated muscles, and the mean fiber cross-section area was also slightly increased, as shown in Figure 6c . only 142 were present in β-galactosidase electroporated muscles.
Improved Myoblast Transplantation With the Trichostatin A Treatment Increased Fiber Cross-Section Area in TA Muscles of mdx Mice Treated With Trichostatin A
Immunohistochemistry against dystrophin permitted to evaluate the success of myoblast transplantation with Histological evaluation of TA muscles from untreated and TSA-treated mdx mice illustrates an increase and without TSA treatment (Fig. 7a ). Dystrophin-positive fibers were counted in each condition. Figure 7b in muscle fiber cross-section area (Fig. 6a ). Frequency histogram of fiber cross-section area illustrates the pres-shows that the myoblast transplantation success was increased by 30% with TSA treatment compared to the ence of larger muscle fibers in TSA-treated mdx mice than in untreated control mdx mice (Fig. 6b ). In addition, control condition. Indeed, with TSA treatment 200 dys- trophin-positive fibers were counted while only 150 increased the success of normal myoblast transplantation. were counted in control muscle sections.
Indeed, in the first part of the article concerning DISCUSSION transgenic dystrophic mice overexpressing the follistatin in their muscles, we have demonstrated first that both Our results demonstrated that blocking endocrine myostatin by the induction of follistatin secretion in dys-whole body and individual TA muscle weights were increased in those transgenic dystrophic mice compared trophic mice-either by generating transgenic dystrophic mice, by a follistatin plasmid electrotransfer in with control dystrophic (nontransgenic) mice. We think that this observation is due to the inhibition of locally transplanted muscles, or by an indirect follistatin induction in muscles via a TSA treatment-not only increased present myostatin and probably other members of TGFβ family such as GDF-11, which is highly related to the whole body weight and the muscle mass, but also myostatin, by the overexpressed follistatin (15). Follis-mice performed better in both rota-rod and force grip assays. Indeed, as mdx mice treated with myostatin block-tatin is known to antagonize several members of the TGF-β family, including myostatin, by its association ing antibodies (4), mdx mice overexpressing the follistatin protein performed better than control mice, proba-with the active C-terminal dimer of myostatin blocking its ability to bind to receptors (13).
bly due to their increased muscle mass and strength. In addition, the grip strength of these transgenic dystrophic This augmentation in whole body and TA muscle weight is also explained in part by an hypertrophy of mice was also increased compared to control mice. Such results were also observed in mdx mice lacking myos-myofibers due to reduced myostatin suppression of the stem cell proliferation and/or differentiation (17). As tatin (28).
These results demonstrate that blocking myostatin at-transgenic mice expressing follistatin under the control of a myosin light chain promoter/enhancer (15), the fol-tenuates the severity of muscular dystrophy in dystrophic mice, and improves the muscle function. Finally, listatin transgenic dystrophic mice have an increased number of muscle fibers because there is a reduced my-our results in transgenic hFst/mdx mice also demonstrated that follistatin overexpression in mdx mice en-ostatin activity early during embryonic development. We also showed that the follistatin transgenic dystrophic hanced the success of normal myoblast transplantation.
This result can be explained by the fact that myostatin as Duchenne muscular dystrophy as well as urinary incontinence by myoblast transplantation (16). bound to follistatin is unable to exert its negative effect on transplanted myoblast proliferation and/or differenti-
